• Main office:
  • Russia, Nizhny Novgorod, ul. Rybinskaya, 58
  • Call us:
  • + 7 (831) 282-58-60
  • Main office:
  • Russia, Nizhny Novgorod, ul. Rybinskaya, 58
 

Binnopharm Group buys from Dr. Reddy's two antibacterial drugs

The company «Binnopharm Group» announced that it is acquiring from the Indian Dr. Reddy’s rights to antibacterial drugs «Ciprolet» and «Levolet». They will be implemented in Russia, Belarus and Uzbekistan. The amount of the transaction was not disclosed.

«The acquisition of Ciprolet and Levolet drugs is an important step that strengthens the company’s leadership position in the antibiotic market, one of the key ones for us. These strong brands have already won the trust of millions of consumers and, according to independent analytical agencies, are leading in their market segments. They will be an important addition to our portfolio of branded antibacterial drugs,» said the CEO of Binnopharm Group Rustem Muratov.

According to AlphaRM, in 2020, sales of «Ciprolet» amounted to 8 million packages worth 785.2 million rubles.

In 2021, sales of the drug decreased to 7.2 million packages (10%) and 715.8 million in rubles (9%).

Sales of Levolet in 2020 amounted to 385.6 thousand packages worth 161.2 million rubles.

In 2021, compared to 2020, sales of Levolet decreased by 58% in rubles and in packages, to 162 thousand packages worth 67.9 million rubles.


More detailed: https://pharmvestnik.ru/content/news/Binnofarm-Grupp-pokupaet-u-Dr-Reddy-s-dva-antibakterialnyh-prep...


Теги:  Ciprolet Levolet Binnopharm Group

Возврат к списку

Our advantages

Wide customer base of buyers

Wide customer base of buyers

Well-established logistics of foreign economic supplies

Well-established logistics of foreign economic supplies

Services for registration of reference prices in the CIS

Services for registration of reference prices in the CIS

Registration and promotion services

Registration and promotion services